Archive for the ‘Diabetic Retinopathy’ Category

White rice linked to higher diabetes risk: study

Wednesday, June 16th, 2010

A US-based study on Monday linked eating white rice to higher risk of developing type 2 diabetes, and backed long-held claims that brown rice is healthier than the white variety.

People who ate at least five servings of white rice per week had a 17 percent greater risk of developing diabetes than those who consumed less than one serving per month, Harvard School of Public Health scientists found.

“These findings could have even greater implications for Asian and other populations in which rice is a staple food.”

Editor’s Note:  For more information on diabetes/diabetic retinopathy, Click Here

Post to Twitter Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Reddit This Post Post to StumbleUpon

Diabetic Retinopathy Linked to Sleep Apnea

Friday, June 11th, 2010

Research presented at the American Thoracic Society’s 105th International Conference indicates patients with diabetes who have retinopathy should also be screened for obstructive sleep apnea (OSA) because evidence strongly suggests a link between the two conditions.  “We know from our earlier research that 23 percent of men with type 2 diabetes have OSA and this is under-recognized and under-treated,” said Sophie D. West, M.D., of the Oxford Centre for Respiratory Medicine in the United Kingdom, who led the research.”  Sleep apnea is marked by snoring, periods of when breathing stops during sleep, and daytime sleepiness.  OSA can be diagnosed through a sleep study and can be treated with the help of a continuous positive airway pressure (CPAP) device.

Source: http://www.medicalnewstoday.com/articles/150754.php

Post to Twitter Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Reddit This Post Post to StumbleUpon

Promising Therapies for Diabetic Macular Edema

Sunday, June 6th, 2010

Laser therapy, also called laser photocoagulation, is more effective and produces fewer side effects than corticosteroids injected into the eye for the treatment of diabetic macular edema according to a large, two-year multicenter study reported in the journal Ophthalmology (Volume 115, page 1447).

For more details, Click Here

Editor’s Note: For more information in nutrition and diabetes/diabetic retinopathy, Click Here

Post to Twitter Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Reddit This Post Post to StumbleUpon

Clinical Trial for Diabetic Eye Disease Treatment Now Enrolling Participants

Sunday, April 4th, 2010

The Juvenile Diabetes Research Foundation (JDRF) and The Wilmer Eye Institute of Johns Hopkins University announced that the Ranibizumab for Edema of the mAcula in Diabetes – Protocol 3 with High Dose Study (READ 3 Study) has begun enrolling participants and will evaluate the safety and efficacy of injections of an antibody treatment in people with diabetic macular edema (DME).

For more information on the above, go to www.trials.jdrf.org

For more information on nutrition and diabetic retinopathy, go to www.naturaleyecare.com/diseases.asp?d_num=4

Post to Twitter Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Reddit This Post Post to StumbleUpon

Tricor doesn’t reduce diabetics’ heart risk

Wednesday, March 17th, 2010

A drug taken for decades by millions of people with type 2 diabetes to prevent heart attacks, strokes and deaths offered no benefit in a broad group of patients, a study released Sunday shows. Fenofibrate, sold as Tricor, lowers triglycerides and boosts good cholesterol, seemingly lowering heart risk. But in most type 2 diabetes patients, it failed to achieve the goal of reducing a combination of heart attacks, strokes and deaths, says lead investigator Henry Ginsberg of Columbia University.

Editor’s Note: Diabetic sufferers are at high risk of onset of diabetic retinopathy which can lead to permanent vision loss. Click Here for information on nutrients (such as alpha lipoic acid, taurine, bilberry, lutein, omega-3 fatty acids) related to helping preserve vision for those with diabetes.

Post to Twitter Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Reddit This Post Post to StumbleUpon

Block Absorption of Killer Carbohydrates

Sunday, February 14th, 2010

According to 2007 data from the National Institutes of Health, 25% of Americans 20 years and older had abnormally high levels of glucose in the blood—a pre-diabetic state. That number leapt to 35% in individuals 60 and older. Extrapolating from the total US population, nearly 60 million American adults may now be pre-diabetic. (reference available at http://diabetes.niddk.nih.gov/DM/PUBS/statistics/#youngpeople. Accessed November 30, 2009).

  • Roughly 1 in 5 Americans are pre-diabetic, a result of excess carbohydrate consumption.
  • The digestive enzymes sucrase, amylase, and glucosidase are primarily responsible for enabling carbohydrate absorption into the blood.
  • L-arabinose—a natural but largely indigestible sugar—blocks sucrase activity, preventing the sugar sucrose from entering the bloodstream.
  • Extracts of white bean, seaweed, and Irvingia block the breakdown of starch in the intestine, preventing their calories from being absorbed.
  • Green tea extract helps your body burn additional calories at rest.
  • Collectively, these natural compounds may dramatically inhibit total carbohydrate intake, limit postprandial blood sugar and insulin spikes, and generate weight loss.

Editor’s Note: See more information on nutrition, diabetes and diabetic retinopathy

Post to Twitter Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Reddit This Post Post to StumbleUpon

Study updates data from M.A. Babizhayev and colleagues on cataracts and n-acetyl-carnosine

Sunday, January 31st, 2010

Updated research continues to show the effectiveness of using eyedrops with 1% n-acetyl-carnosine solutions for preventing and managing cataracts. Research also indicates these eyedrops may help other eye conditions such as age-related macular degeneration, primary open-angle glaucoma and diabetic retinopathy.

Dr. Babizhayev and colleagues published their study in American Journal of Therapeutics (N-Acetylcarnosine Lubricant Eyedrops Possess All-In-One Universal Antioxidant Protective Effects of L-Carnosine in Aqueous and Lipid Membrane Environments, Aldehyde Scavenging, and Transglycation Activities Inherent to Cataracts: A Clinical Study of. American Journal of Therapeutics, UNKNOWN DATE;16(6):517-533).

Editor’s Note: For information on Can-C eyedrops (1% n-acetyl-carnosine eyedrops), go to www.naturaleyecare.com/store/detail.aspx?ID=1831

Post to Twitter Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Reddit This Post Post to StumbleUpon

Soy peptide lunasin has anti-cancer, anti-inflammatory properties

Tuesday, December 15th, 2009

Two new University of Illinois studies report that lunasin, a soy
peptide often discarded in the waste streams of soy-processing
plants, may have important health benefits that include fighting
leukemia and blocking the inflammation that accompanies such
chronic health conditions as diabetes, rheumatoid arthritis, heart
disease, and stroke (see also University of Illinois at
Urbana-Champaign).

In another study, the first to report lunasin’s potential
anti-inflammatory activity, they showed that lunasin blocked or
reduced the activation of an important marker called NF-kappa-B,
a link in the chain of biochemical events that cause inflammation.

Lunasin’s bioavailability in the human body was confirmed by doing a
third study in which men consumed 50 grams of soy protein–one soy
milk shake and a serving of soy chili daily–for five days.

Editor’s Note1: Note that soy flour does contain high concentrations of the peptide.
Editor’s Note2: Chronic systemic inflammation can cause or contribute to many eye conditions such as macular degeneration, diabetic retinopathy, macula edema, optic neuritis, uveitis and iritis for example. Chronic inflammation is now considered a major contributor to heart disease as well.

For more information on ways to help manage inflammation nutritionally, Click Here

Post to Twitter Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Reddit This Post Post to StumbleUpon

Studies Show Benefits of Pomegranate Juice in Preventing Heart Disease

Monday, November 23rd, 2009

Atherosclerosis (hardening of the arteries) is a leading killer of older adults. Pomegranate extracts work at every step in the deadly atherosclerosis cascade to prevent or reverse the damage, thereby extending life.

Ref: Nutr Rev. 2009 Jan;67(1):49-56.
Mol Nutr Food Res. 2009 Mar;53(3):322-31.

Pomegranate juice helps protect the heart by reducing inflammation, reducing LDL (low density lipoproteins), as well as reducing oxidative stress and platelet clumping,

Studies also indicates pomegranate juice has anti-cancer properties and helps lower blood sugar for diabetics and pre-diabetics.

Healthy circulation is critical for helping prevent eye disease. For related information, go to www.naturaleyecare.com

Post to Twitter Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Reddit This Post Post to StumbleUpon

Researchers Predict Number of Americans with Diabetic Retinopathy Will Soar By 2050

Sunday, November 22nd, 2009

The number of Americans with diabetic retinopathy is expected to increase from 5.5 million to 16 million by the year 2050.  Diabetic retinopathy is damage to the retina caused by complications of diabetes, which can eventually lead to blindness.

Researchers used data from the National Health Interview Survey and the US Census Bureau to project the number of people with diabetic retinopathy (DR), vision-threatening DR (VTDR), glaucoma, and cataracts among Americans 40 years or older with diagnosed diabetes mellitus for the years 2005-2050.

Study results showed:

  • the number of Americans 40 years or older with DR will triple from 5.5 million in 2005 to 16.0 million in 2050
  • the number of Americans 40 years or older with VTDR will also triple, from 1.2 million in 2005 to 3.4 million in 2050
  • increases among those 65 years or older will be more pronounced (2.5 million to 9.9 million for DR and 0.5 million to 1.9 million for VTDR)
  • the number of cataract cases among whites and blacks 40 years or older with diabetes will likely increase 235% by 2050, and 
  • the number of glaucoma cases among Hispanics with diabetes 65 years or older will increase 12-fold.

Study authors stress the importance of efforts to prevent diabetes as well as to optimally manage diabetes and its complications.

SOURCE:  Projection of Diabetic Retinopathy and Other Major Eye Diseases Among People With Diabetes Mellitus, Saaddine, et al, Arch Ophthalmol. 2008;126(12):1740-1747.

Post to Twitter Post to Delicious Post to Digg Post to Facebook Post to MySpace Post to Reddit Reddit This Post Post to StumbleUpon

Twitter links powered by Tweet This v1.6.1, a WordPress plugin for Twitter.